Interleukin‐18 serum level before and after intralesional immunotherapy with tuberculin purified protein derivative in patients with cutaneous and genital warts

• Published in: Journal of cosmetic dermatology Vol. 21; no. 12; pp. 7035 - 7042
• Main Authors: Korsa, Hadeer Hazem Abo, Nashaat, Hebat‐Allah Hassan, Halim, Halim Maher, Atwa, Mona A., Mahmoud Marie, Radwa El‐Sayed
• Format: Journal Article
• Language: English
• Published: England 01.12.2022
• Subjects: Condylomata Acuminata - chemically induced; Humans; Immunotherapy - adverse effects; infection; Injections, Intralesional; Interleukin-18 - therapeutic use; Interleukin‐18; Treatment Outcome; Tuberculin - adverse effects; viral warts; Warts - drug therapy; Interleukin-18; viral warts; infection

Background Several studies demonstrated the efficacy of intralesional purified protein derivative (PPD) immunotherapy in warts eradication. Nevertheless, the precise induced immune mechanisms are undetermined. Injected PPD is hypothesized to induce a delayed hypersensitivity reaction associated with...